CD40FasL inhibits human T cells: evidence for an auto-inhibitory loop-back mechanism

By Dranitzki-Elhalel M.   Huang J. H.   Sasson M.   Rachmilewitz J.   Parnas M.   Tykocinski M. L.  

International Immunology, Vol. 19, Iss. 4, 2007-04 ,pp. : 355-363

Oxford University Press

Access to resources Recommend Favorite

Analysis of Biochemical and Biological Functions of Fas-Ligand (FasL) and Fas on Activated T Cells in Allo-Immune Response

By Nakajima H.   Oka T.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1096-1100

Elsevier

Access to resources Recommend Favorite

FasL expression on pig cells suppresses human natural killer cell mediated-cytotoxicity

By Nakajima H.   Fujiwara I.   Matsuda T.   Mizuta N.   Yamagishi H.   Oka T.   Yoshimura N.  

Transplantation Proceedings, Vol. 31, Iss. 7, 1999-11 ,pp. : 2704-2706

Elsevier

Access to resources Recommend Favorite

Correlation of Loss of CD4 T Cells with Plasma Levels of Both Soluble Form Fas (CD95) and Fas Ligand (FasL) in HIV-Infected Infants

By Hosaka N.   Oyaizu N.   Than S.   Pahwa S.  

Clinical Immunology, Vol. 95, Iss. 1, 2000-04 ,pp. : 20-25

Academic Press

Access to resources Recommend Favorite

Blocking of the B7-CD28 Pathway Increases Apoptosis Induced in Activated T Cells by In Vitro-Generated CD95L (FasL) Positive Dendritic Cells

By Lu L.   Qian S.   Hershberger P.   Rudert W.A.   Li Y.   Chambers F.G.   Starzl T.E.   Lynch D.H.   Thomson A.W.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 1094-1095

Elsevier

Access to resources Recommend Favorite